Trial Profile
Comparison of the efficacy of everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side branch stenting.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Mar 2011
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 11 Mar 2011 New trial record